1. 1 Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, et al.: The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019-5032, 2011
2. 2 Ansell SM, Kyle RA, Reeder CB, Fonseca R, Mikhael JR, et al.: Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc 85:824-833, 2010
3. 3 Ghobrial IM, Witzig TE: Waldenström macroglobulinemia. Curr Treat Options Oncol 5:239-247, 2004
4. 4 Braggio E, Philipsborn C, Novak A, Hodge L, Ansell S, et al.: Molecular pathogenesis of Waldenström's macroglobulinemia. Haematologica 97:1281-1290, 2012
5. 5 Morice WG, Chen D, Kurtin PJ, Hanson CA, McPhail ED: Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia. Mod Pathol 22:807-816, 2009